Dorsey ER, Sherer T, Okun MS, Bloem BR (2018) The emerging evidence of the Parkinson pandemic. J Parkinsons Dis 8(s1):S3-s8. https://doi.org/10.3233/jpd-181474

Article  PubMed  PubMed Central  Google Scholar 

de Klerk GW, van Laar T, Meles SK (2024) A retrospective study of the MDS criteria for prodromal Parkinson’s disease in the general population. NPJ Parkinsons Dis 10(1):125. https://doi.org/10.1038/s41531-024-00739-6

Article  PubMed  PubMed Central  Google Scholar 

Stocchi F, Bravi D, Emmi A, Antonini A (2024) Parkinson disease therapy: current strategies and future research priorities. Nat Rev Neurol 20(12):695–707. https://doi.org/10.1038/s41582-024-01034-x

Article  PubMed  Google Scholar 

Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22(11):657–673. https://doi.org/10.1038/s41577-022-00684-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roodveldt C, Bernardino L, Oztop-Cakmak O, Dragic M, Fladmark KE, Ertan S, Aktas B, Pita C, et al. (2024) The immune system in Parkinson’s disease: what we know so far. Brain 147(10):3306–3324. https://doi.org/10.1093/brain/awae177

Article  PubMed  PubMed Central  Google Scholar 

Imamura K, Hishikawa N, Sawada M, Nagatsu T, Yoshida M, Hashizume Y (2003) Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson’s disease brains. Acta Neuropathol 106(6):518–526. https://doi.org/10.1007/s00401-003-0766-2

Article  CAS  PubMed  Google Scholar 

Gao C, Jiang J, Tan Y, Chen S (2023) Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther 8(1):359. https://doi.org/10.1038/s41392-023-01588-0

Article  PubMed  PubMed Central  Google Scholar 

Wang T, Sun Y, Dettmer U (2023) Astrocytes in Parkinson’s disease: from role to possible intervention. Cells. https://doi.org/10.3390/cells12192336

Article  PubMed  PubMed Central  Google Scholar 

Lind-Holm Mogensen F, Seibler P, Grünewald A, Michelucci A (2025) Microglial dynamics and neuroinflammation in prodromal and early Parkinson’s disease. J Neuroinflammation 22(1):136. https://doi.org/10.1186/s12974-025-03462-y

Article  PubMed  PubMed Central  Google Scholar 

Rietdijk CD, Perez-Pardo P, Garssen J, van Wezel RJ, Kraneveld AD (2017) Exploring Braak’s hypothesis of Parkinson’s disease. Front Neurol 8:37. https://doi.org/10.3389/fneur.2017.00037

Article  PubMed  PubMed Central  Google Scholar 

Evancho A, Do M, Fortenberry D, Billings R, Sartayev A, Tyler WJ (2024) Vagus nerve stimulation in Parkinson’s disease: a scoping review of animal studies and human subjects research. NPJ Parkinsons Dis 10(1):199. https://doi.org/10.1038/s41531-024-00803-1

Article  PubMed  PubMed Central  Google Scholar 

Nishiwaki H, Ueyama J, Ito M, Hamaguchi T, Takimoto K, Maeda T, Kashihara K, Tsuboi Y, et al. (2024) Meta-analysis of shotgun sequencing of gut microbiota in Parkinson’s disease. NPJ Parkinsons Dis 10(1):106. https://doi.org/10.1038/s41531-024-00724-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krueger ME, Boles JS, Simon ZD, Alvarez SD, McFarland NR, Okun MS, Zimmermann EM, Forsmark CE, et al. (2025) Comparative analysis of Parkinson’s and inflammatory bowel disease gut microbiomes reveals shared butyrate-producing bacteria depletion. NPJ Parkinsons Dis 11(1):50. https://doi.org/10.1038/s41531-025-00894-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nishiwaki H, Ito M, Ishida T, Hamaguchi T, Maeda T, Kashihara K, Tsuboi Y, Ueyama J, et al. (2020) Meta-analysis of gut dysbiosis in Parkinson’s disease. Mov Disord 35(9):1626–1635. https://doi.org/10.1002/mds.28119

Article  CAS  PubMed  Google Scholar 

Nie K, Ma K, Luo W, Shen Z, Yang Z, Xiao M, Tong T, Yang Y, et al. (2021) Roseburia intestinalis: a beneficial gut organism from the discoveries in genus and species. Front Cell Infect Microbiol 11:757718. https://doi.org/10.3389/fcimb.2021.757718

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kang X, Liu C, Ding Y, Ni Y, Ji F, Lau HCH, Jiang L, Sung JJ, et al. (2023) Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8(+) T cells. Gut 72(11):2112–2122. https://doi.org/10.1136/gutjnl-2023-330291

Article  CAS  PubMed  Google Scholar 

Bircher A, Katkeviciute E, Morsy Y, Lang S, Montalban-Arques A, Scharl M (2025) Roseburia intestinalis modulates immune responses by inducing M1 macrophage polarization. Int J Mol Sci. https://doi.org/10.3390/ijms26115049

Article  PubMed  PubMed Central  Google Scholar 

Shen Z, Zhu C, Quan Y, Yang J, Yuan W, Yang Z, Wu S, Luo W, et al. (2018) Insights into Roseburia intestinalis which alleviates experimental colitis pathology by inducing anti-inflammatory responses. J Gastroenterol Hepatol 33(10):1751–1760. https://doi.org/10.1111/jgh.14144

Article  CAS  PubMed  Google Scholar 

Kasahara K, Krautkramer KA, Org E, Romano KA, Kerby RL, Vivas EI, Mehrabian M, Denu JM, et al. (2018) Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model. Nat Microbiol 3(12):1461–1471. https://doi.org/10.1038/s41564-018-0272-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tilg H, Moschen AR (2014) Microbiota and diabetes: an evolving relationship. Gut 63(9):1513–1521. https://doi.org/10.1136/gutjnl-2014-306928

Article  CAS  PubMed  Google Scholar 

Shao X, Li M, Shi S, Wu T, Zhang Y, Guo S, Lin H, Qi X (2025) Neuroprotective effects of Paeonia lactiflora through the regulation of gut Dubosiella in an MPTP-induced Parkinson’s disease mouse model. Am J Chin Med 53(3):833–862. https://doi.org/10.1142/s0192415x25500314

Article  CAS  PubMed  Google Scholar 

Zhang Y, Tu S, Ji X, Wu J, Meng J, Gao J, Shao X, Shi S, et al. (2024) Dubosiella newyorkensis modulates immune tolerance in colitis via the L-lysine-activated AhR-IDO1-Kyn pathway. Nat Commun 15(1):1333. https://doi.org/10.1038/s41467-024-45636-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Björklund T, Wang ZY, Roybon L, et al. (2014) Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol 128(6):805–820. https://doi.org/10.1007/s00401-014-1343-6

Article  PubMed  Google Scholar 

Wang L, Zhao Z, Zhao L, Zhao Y, Yang G, Wang C, Gao L, Niu C, et al. (2022) Lactobacillus plantarum DP189 reduces α-SYN aggravation in MPTP-induced Parkinson’s disease mice via regulating oxidative damage, inflammation, and gut microbiota disorder. J Agric Food Chem 70(4):1163–1173. https://doi.org/10.1021/acs.jafc.1c07711

Article  CAS  PubMed  Google Scholar 

Dong Y, Qi Y, Chen J, Han S, Su W, Ma X, Yu Y, Wang Y (2024) Neuroprotective effects of Bifidobacterium animalis subsp. lactis NJ241 in a mouse model of Parkinson’s disease: implications for gut microbiota and PGC-1α. Mol Neurobiol 61(10):7534–7548. https://doi.org/10.1007/s12035-024-04038-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bedarf JR, Hildebrand F, Coelho LP, Sunagawa S, Bahram M, Goeser F, Bork P, Wüllner U (2017) Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients. Genome Med 9(1):39. https://doi.org/10.1186/s13073-017-0428-y

Article  CAS  PubMed